Fungal metabolites, ML-236A and ML-236B, were isolated from cultures of Penicillium citrinum as potent inhibitors of cholesterol synthesis in vitro.It was shown that ML-236A and ML-236B inhibit specifically 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase, the rate limiting enzyme in cholesterol synthetic pathway, without affecting the rest of the enzymes involved in this pathway, and that the inhibition is competitive with respect to the substrate HMG-CoA.The α-methylbutyrate residue of ML-236B appears to play a significant role in the inhibition of HMG-CoA reductase, since both lactone and acid forms of ML-236A, lacking such a residue in their structure, are far less inhibitory than ML-236B analogs.The acid forms of both ML-236A and ML-236B contain a portion having a chem. structure very similar to that of 3-hydroxy-3-methylglutarate.This is compatible with the fact that these compounds are competitive inhibitors of HMG-CoA reductase and further that the acid forms are more potent than the corresponding lactone forms.The results obtained in this study provide good evidence that a specific inhibitor of HMG-CoA reductase is effective in reducing cholesterol synthesis in vivo, and thereby in lowering cholesterol levels in blood.